SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                   -------------------------------------------


                                    FORM 8-K


                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



                                 Date of Report
                       (Date of earliest event reported):

                                December 14, 1998

                    ----------------------------------------


                            TREX MEDICAL CORPORATION
             (Exact name of Registrant as specified in its charter)


Delaware                        1-11827                    06-1439626
(State or other               (Commission               (I.R.S. Employer
jurisdiction of               File Number)             Identification Number)
incorporation or
organization)


37 Apple Ridge Road
Danbury, Connecticut                                        06810
 (Address of principal executive offices)                 (Zip Code)


                                (203) 207-4500
                         (Registrant's telephone number
                              including area code)



<PAGE>








     This Form 8-K contains forward-looking  statements that involve a number of
risks and  uncertainties.  Important  factors that could cause actual results to
differ  materially from those indicated by such  forward-looking  statements are
set forth under the heading  "Forward-looking  Statements"  in Exhibit 13 to the
Registrant's  Annual Report on Form 10-K for the fiscal year ended September 27,
1997. These include risks and uncertainties  relating to: technological  change,
product development and  commercialization,  competition,  dependency on patents
and proprietary  rights,  intellectual  property,  litigation,  the Registrant's
acquisition strategy,  government  regulation and approvals,  healthcare reform,
patient  reimbursement,  dependence on significant OEM relationships,  potential
product  liability,  international  operations,  and the potential impact of the
year 2000 on processing date-sensitive information.

Item 5.     Other Events

      On December 14, 1998, the Registrant  issued a press release regarding (i)
the resignation of its president and chief executive officer, Hal Kirshner,  and
(ii) its anticipation that earnings for its first fiscal quarter, ending January
2, 1999, will be approximately breakeven due to lower-than-expected revenues.


Item 7.     Financial Statements, Pro Forma Financial Information and Exhibits

      (a)   Financial Statements of Business Acquired: not
            applicable.

      (b)   Pro Forma Financial Information: not applicable.

      (c)   Exhibits: not applicable.






<PAGE>




                                    SIGNATURE



      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized, on this 14th day of December, 1998.



                                          TREX MEDICAL CORPORATION


                                          By:/s/ Kenneth J. Apicerno
                                             Kenneth J. Apicerno
                                             Treasurer
[{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 3418}]
{"company-data": {"conformed-name": "TREX MEDICAL CORP", "cik": "0001003539", "assigned-sic": "3844", "irs-number": "061439626", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11827", "film-number": "98769151"}, "business-address": {"street1": "36 APPLE RIDGE RD", "street2": "P.O. BOX 9046", "city": "DANBURY,", "state": "CT", "zip": "06810", "phone": "2037901188"}, "mail-address": {"street1": "81 WYMAN STREET", "street2": "P.O. BOX 9046", "city": "WALTHAM", "state": "MA", "zip": "02254"}}
SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                   -------------------------------------------

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                                 Date of Report
                       (Date of earliest event reported):

                                December 14, 1998

                    ----------------------------------------

                            TREX MEDICAL CORPORATION
             (Exact name of Registrant as specified in its charter)

Delaware                        1-11827                    06-1439626
(State or other               (Commission               (I.R.S. Employer
jurisdiction of               File Number)             Identification Number)
incorporation or
organization)

37 Apple Ridge Road
Danbury, Connecticut                                        06810
 (Address of principal executive offices)                 (Zip Code)

                                (203) 207-4500
                         (Registrant's telephone number
                              including area code)
This Form 8-K contains forward-looking  statements that involve a number of
risks and  uncertainties.  Important  factors that could cause actual results to
differ  materially from those indicated by such  forward-looking  statements are
set forth under the heading  "Forward-looking  Statements"  in Exhibit 13 to the
Registrant's  Annual Report on Form 10-K for the fiscal year ended September 27,
1997. These include risks and uncertainties  relating to: technological  change,
product development and  commercialization,  competition,  dependency on patents
and proprietary  rights,  intellectual  property,  litigation,  the Registrant's
acquisition strategy,  government  regulation and approvals,  healthcare reform,
patient  reimbursement,  dependence on significant OEM relationships,  potential
product  liability,  international  operations,  and the potential impact of the
year 2000 on processing date-sensitive information.

Item 5.     Other Events

      On December 14, 1998, the Registrant  issued a press release regarding (i)
the resignation of its president and chief executive officer, Hal Kirshner,  and
(ii) its anticipation that earnings for its first fiscal quarter, ending January
2, 1999, will be approximately breakeven due to lower-than-expected revenues.

Item 7.     Financial Statements, Pro Forma Financial Information and Exhibits

      (a)   Financial Statements of Business Acquired: not
            applicable.

      (b)   Pro Forma Financial Information: not applicable.

      (c)   Exhibits: not applicable.
SIGNATURE

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized, on this 14th day of December, 1998.

                                          TREX MEDICAL CORPORATION

                                          By:/s/ Kenneth J. Apicerno
                                             Kenneth J. Apicerno
                                             Treasurer